Most Recent

Chinese AI firms rolled out a slate of new releases at this year’s WAIC, signaling no slowdown in development.

As patent cliffs approach and new mechanisms gain ground, COPD drugs like HRS-9821 are fast becoming coveted assets.

Collaboration was central to shaping the Li i8’s defining strengths.

Companies are buying rivals and tapping into e-commerce to gain market share.

Two new features expand Kling AI’s capabilities, pushing it closer to production-grade applications.

Smart, spacious, and designed for volume, the Shangjie H5 sets out to reshape expectations for the RMB 200,000 SUV tier.

Bringing you the latest updates on funding deals and activities in the Asia Pacific.

The sportswear giant lifted H1 2025 revenue by 14% even as tariff risks loom.

Dianzhong’s plagiarism accusation adds pressure to an already tense, fast-moving content race.

Once the go-to for in-vehicle chips, Nvidia is facing defections from Chinese carmakers amid delays, performance setbacks, and cultural disconnect.